Articles by K V Venkatasubramanian

Even as the UK, US and other countries have started vaccinating their citizens, India is yet to start immunising its massive population, as the final human trials are not yet over. The task is difficult and poses unique challenges. Citizen Matters spoke to four eminent experts on their views on the vaccine and the various challenges of a mass vaccination drive: Dr Satyajit Rath: Visiting Professor, Indian Institute of Science Education and Research (IISER), Pune.Dr Shahid Jameel: Director, Trivedi School of Biosciences, Ashoka University, Sonipat, Haryana.Dr Rakesh Mishra: Director, CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad.Prof Nirmal Kumar Ganguly:…

Health workers at a Boston hospital broke into a celebratory dance on receiving their first doses of COVID-19 vaccine recently. In India, even before the vials are ready, competition is emerging over who will have the first access. With the vaccine in the final trial phase, India faces the looming challenge of producing the quantities necessary to provide immunity to all its citizens.  Globally, pharma companies are racing ahead to roll out vaccines to fight COVID-19, including the new highly infectious strain that has been found in Britain. Daily life cannot find a new normal until populations have built up antibodies…

On a busy noon last week, as Kavya, 63, was scouting for medicine for her husband at the Yusuf Sarai market in south Delhi, she noticed that salesmen in many drug stores were either without masks, or were not covering their nose and mouth. The elbowing crowd of customers, too, were not wearing masks. “I got terribly scared and was virtually in tears,” says a frightened Kavya as she rushed out of the shop. This market is lined with more than 50 drug stores as two big hospitals—AIIMS and the Safdarjung—are in proximity.  At the giant commercial-cum-office complex at Nehru…